Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-25-007679

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 8,902.8 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-07 Grant or award : show line 1 in the form Deferred Stock Units +8,902.8 $11.14 $99,177 14,858.54 D
Loading xslF345X05/form4-03112025_090346.xml…